AusPAR: Golimumab (rmc)

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

18 June 2014
AusPAR Details
AusPAR
Active Ingredient
Golimumab (rmc)
Product Name
Simponi, Simponi smartject injector
Sponsor
Janssen-Cilag Pty Ltd
Submission Number
PM-2013-00215-1-1
Submission Type
Major variation (extension of indications)
Decision
Approved
AusPAR Date
19 May 2014
Publication Date

18 June 2014